BioScrip sees growth in home infusion

 - 
Wednesday, March 4, 2015

ELMSFORD, N.Y. – BioScrip on March 2 reported revenues of $253.7 million for the fourth quarter of 2014, a 12.5% increase over the same period in 2013. Of that, home infusion contributed $239.5 million in revenues, an increase of 13%; PBM contributed $14.2 million in revenues vs. $13.5 million. Total revenues for the 12 months ended Dec. 31, 2014, were $984.1 million compared to $769.5 million for 2013, a 27.9% increase, driven primarily by organic growth in home infusion.